Xantho Biotechnology Co., Ltd
Clinical trials sponsored by Xantho Biotechnology Co., Ltd, explained in plain language.
-
Can a new gel calm psoriasis Flare-Ups?
Disease control Not yet recruitingThis trial tests whether a topical gel called GM-XANTHO can reduce the severity of psoriasis, a chronic skin condition that causes red, scaly patches. About 65 adults with plaque psoriasis will apply the gel or a placebo daily for 28 days. Researchers will measure changes in skin…
Phase: PHASE2 • Sponsor: Xantho Biotechnology Co., LTD • Aim: Disease control
Last updated Aug 09, 2026 00:00 UTC
-
New ointment aims to heal bedsores faster in diabetic patients
Disease control Not yet recruitingThis study tests an ointment called GM-XANTHO for treating stage II or III pressure ulcers (bedsores) in people with diabetes. About 58 participants will receive either a low or high dose of the ointment or a placebo, along with standard care. The goal is to see if the ointment h…
Phase: PHASE2 • Sponsor: Xantho Biotechnology Co., LTD • Aim: Disease control
Last updated Jun 26, 2026 12:54 UTC